RecruitingNot Applicable

The Impact of Artificial Intelligence Electrocardiography on Occlusion Myocardial Infarction Management Under the Value-Based Payment System

Taiwan212,000 participantsStarted 2025-08-01

Plain-language summary

This trial will prospectively evaluate the impact of integrating AI-ECG within the pay-for-performance program on improving the diagnosis, treatment, and clinical outcomes of occlusion myocardial infarction patients by promoting accurate and timely diagnoses through financial incentives.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients in the emergency department * Patients received at least 1 ECG examination. Exclusion Criteria: * The patients received ECG at the period of inactive AI-ECG system. * Patients with a history of coronary angiography within the past 3 days.

What they're measuring

D-to-W time (Door to Wire Time)

Timeframe: From the start of the emergency visit to the following 48 hours.

Cost Outcome Measure

Timeframe: From the start of the emergency visit to 90 days post-discharge.

Trial details

NCT IDNCT06887699

SponsorNational Defense Medical Center, Taiwan

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2028-03-31

Contact for this trial

Chin Lin, PhD

+886-2-8792-3100 xup6fup@mail.ndmctsgh.edu.tw

View on ClinicalTrials.gov More OMI - Occlusion Myocardial Infarction trials